Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Is a |
Product containing benzoic acid (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Benzoic acid |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Salicylic acid (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Is a |
Salicylic acid (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent kératolytique |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Is a |
Benzoic acid- and salicylic acid-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has manufactured dose form |
forme pharmaceutique pour usage transdermique et/ou cutané |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has manufactured dose form |
A semi-solid dose form of homogeneous appearance consisting of a lipophilic phase and an aqueous phase, one of which is finely dispersed in the other. Active substance(s) are dissolved or dispersed in the basis, which may be hydrophilic or hydrophobic. |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Is a |
Product containing salicylic acid in topical dosage form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has manufactured dose form |
Cutaneous cream |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has concentration strength denominator unit (attribute) |
g |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has concentration strength numerator value |
30 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has concentration strength denominator unit (attribute) |
g |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has concentration strength numerator value |
60 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has basis of strength substance (attribute) |
Salicylic acid (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has precise active ingredient |
Benzoic acid |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has basis of strength substance (attribute) |
Benzoic acid |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has precise active ingredient |
Salicylic acid (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Count of base of active ingredient |
deux |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has concentration strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has concentration strength numerator unit |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has concentration strength numerator unit |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Is a |
Product containing only benzoic acid and salicylic acid in cutaneous dose form (medicinal product form) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Plays role |
Antifungal therapeutic role (role) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has precise active ingredient |
Benzoic acid |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has precise active ingredient |
Salicylic acid (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has basis of strength substance (attribute) |
Benzoic acid |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Benzoic acid 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has basis of strength substance (attribute) |
Salicylic acid (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|